advertisement
Komatsu K 12
Showing records 1 to 12 | Display all abstracts from Komatsu K109389 Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery
Ko JA
Current Eye Research 2023; 48: 826-835
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Mizuno Y
Contemporary clinical trials communications 2023; 33: 101160
109389 Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery
Komatsu K
Current Eye Research 2023; 48: 826-835
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Komatsu K; Tokumo K
Contemporary clinical trials communications 2023; 33: 101160
109389 Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery
Minamoto A
Current Eye Research 2023; 48: 826-835
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Okada N
Contemporary clinical trials communications 2023; 33: 101160
109389 Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery
Kondo S; Okumichi H
Current Eye Research 2023; 48: 826-835
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Onoe H; Okumichi H
Contemporary clinical trials communications 2023; 33: 101160
109389 Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery
Hirooka K
Current Eye Research 2023; 48: 826-835
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Hirooka K
Contemporary clinical trials communications 2023; 33: 101160
109389 Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery
Kiuchi Y
Current Eye Research 2023; 48: 826-835
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Miura Y; Kiuchi Y
Contemporary clinical trials communications 2023; 33: 101160